134 related articles for article (PubMed ID: 15509160)
1. Toward a pharmacophore for kinase frequent hitters.
Aronov AM; Murcko MA
J Med Chem; 2004 Nov; 47(23):5616-9. PubMed ID: 15509160
[TBL] [Abstract][Full Text] [Related]
2. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
Aronov AM; McClain B; Moody CS; Murcko MA
J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
[TBL] [Abstract][Full Text] [Related]
3. A pharmacophore map of small molecule protein kinase inhibitors.
McGregor MJ
J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand.
Pagano N; Maksimoska J; Bregman H; Williams DS; Webster RD; Xue F; Meggers E
Org Biomol Chem; 2007 Apr; 5(8):1218-27. PubMed ID: 17406720
[TBL] [Abstract][Full Text] [Related]
6. Application of Free-Wilson selectivity analysis for combinatorial library design.
Sciabola S; Stanton RV; Johnson TL; Xi H
Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
[TBL] [Abstract][Full Text] [Related]
7. The role of structure in kinase-targeted inhibitor design.
Pratt DJ; Endicott JA; Noble ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):428-36. PubMed ID: 15338952
[TBL] [Abstract][Full Text] [Related]
8. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
[TBL] [Abstract][Full Text] [Related]
9. CORES: an automated method for generating three-dimensional models of protein/ligand complexes.
Hare BJ; Walters WP; Caron PR; Bemis GW
J Med Chem; 2004 Sep; 47(19):4731-40. PubMed ID: 15341488
[TBL] [Abstract][Full Text] [Related]
10. Finding protein kinase hits using structural information.
Cherry M; Reader J; Williams D
Prog Med Chem; 2006; 44():1-63. PubMed ID: 16697894
[No Abstract] [Full Text] [Related]
11. Selectivity assessment of kinase inhibitors: strategies and challenges.
Luo Y
Curr Opin Mol Ther; 2005 Jun; 7(3):251-5. PubMed ID: 15977423
[TBL] [Abstract][Full Text] [Related]
12. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
13. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity.
Pratt DJ; Bentley J; Jewsbury P; Boyle FT; Endicott JA; Noble ME
J Med Chem; 2006 Sep; 49(18):5470-7. PubMed ID: 16942020
[TBL] [Abstract][Full Text] [Related]
15. Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.
Simard JR; Getlik M; Grütter C; Schneider R; Wulfert S; Rauh D
J Am Chem Soc; 2010 Mar; 132(12):4152-60. PubMed ID: 20201574
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family.
Cao H; Zhang H; Zheng X; Gao D
J Mol Graph Model; 2007 Jul; 26(1):236-45. PubMed ID: 17293140
[TBL] [Abstract][Full Text] [Related]
17. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
Sheinerman FB; Giraud E; Laoui A
J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
[TBL] [Abstract][Full Text] [Related]
18. Taming the induced folding of drug-targeted kinases.
Fernández A; Bazán S; Chen J
Trends Pharmacol Sci; 2009 Feb; 30(2):66-71. PubMed ID: 19097649
[TBL] [Abstract][Full Text] [Related]
19. Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes.
Singh J; Deng Z; Narale G; Chuaqui C
Chem Biol Drug Des; 2006 Jan; 67(1):5-12. PubMed ID: 16492144
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
Laufer SA; Domeyer DM; Scior TR; Albrecht W; Hauser DR
J Med Chem; 2005 Feb; 48(3):710-22. PubMed ID: 15689155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]